Drug Shortage Report for ACTEMRA
| Report ID | 155146 |
| Drug Identification Number | 02350106 |
| Brand name | ACTEMRA |
| Common or Proper name | ACTEMRA |
| Company Name | HOFFMANN-LA ROCHE LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | TOCILIZUMAB |
| Strength(s) | 200MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 200MG/10ML 1VIAL |
| ATC code | L04AC |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-07-15 |
| Actual start date | |
| Estimated end date | 2022-07-30 |
| Actual end date | 2022-06-22 |
| Shortage status | Avoided shortage |
| Updated date | 2022-07-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2022-02-23 | English | Compare |
| v2 | 2022-02-17 | French | Compare |
| v1 | 2022-02-17 | English | Compare |